Last updated on September 2016

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF


Brief description of study

This study is a randomized, double-blind, placebo-controlled trial in which eligible IPF subjects will be randomized to receive GBT440 or Placebo orally daily.

Clinical Study Identifier: NCT02846324

Find a site near you

Start Over

Tatiana Blue

New York, NY United States
  Connect »

Lisa Weaver

Salt Lake City, UT United States
  Connect »

Marla Watson

Kansas City, KS United States
  Connect »

Ashley Warden

Charleston, SC United States
  Connect »

Cori Fratelli

Denver, CO United States
  Connect »

Sharonda Keazor

Birmingham, AL United States
  Connect »

Edwinia Battle

Falls Church, VA United States
  Connect »

Francine McGonagle

Philadelphia, PA United States
  Connect »

Sandy Ditta

New Orleans, LA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.